Acute Cardiovascular Care 2016

15 - 17 October 2016, Lisbon - Portugal

Session Details

Poster Session 3: Antithrombotic therapy
Sun 16 Oct 08:30 - 12:30 Miscellaneous Poster Session Poster Area -

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
08:30P497Protocol-based management of warfarin pharmacotherapy by pharmacists in perioperative cardiac surgery patientsMasanori SUZUKI (Kamogawa, Japan)
08:30P498High on-treatment after aspirin loading dose platelet reactivity as a modifiable risk factor to tailor antiplatelet therapy in acute coronary syndromeLidia MALINOVA (Saratov, Russian Federation)
08:30P499Prognostic impact of single antiplatelet therapy as a primary prevention strategy in the acute coronary syndromes settingLuis ALMEIDA MORAIS (Lisbon, Portugal)
08:30P500Acute coronary syndrome and atrial fibrillation: benefit versus risk of triple antithrombotic therapySara GUERREIRO (Faro, Portugal)
08:30P501Safety and efficacy of new antiplatelet drugs in elderly patients with acute coronary syndrome (SCENARIO I study)Luis Maria MADRONA JIMENEZ (Sevilla, Spain)
08:30P502Dual antiplatelet therapy in acute coronary syndrome, how long should we maintain it? Mercedes MERCHAN CUENDA (Salvaleon, Spain)
08:30P503New antiplatelet agents in acute coronary syndromeCatarina Sofia SOARES DE SA (Valongo, Portugal)
08:30P504Triple antithrombotic therapy after acute coronary syndromeRoberto PINTO (Matosinhos, Portugal)
08:30P505Impact assessment of an educational program in myocardial infarction guidelines adherence. Juan Carlos GOMEZ POLO (Madrid, Spain)
08:30P506ATTAIN-Registry: Use of P2Y12-inhibitors in patients presenting with acute coronary syndrome in AustriaMaximilian TSCHARRE (Vienna, Austria)
08:30P507Safety of switching to new antiplatelets in acute coronary syndrome with ST segment elevation, a monocentric experienceRafael Carlos VIDAL PEREZ (Santiago De Compostela, Spain)